CADL
Candel Therapeutics (CADL)
$61
About Candel Therapeutics (CADL)
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Details
Daily high
$5.89
Daily low
$5.56
Price at open
$5.89
52 Week High
$13.68
52 Week Low
$4.25
Market cap
325.0M
Dividend yield
0.00%
Volume
384,241
Avg. volume
727,394
P/E ratio
-10.58
Candel Therapeutics News
Details
Daily high
$5.89
Daily low
$5.56
Price at open
$5.89
52 Week High
$13.68
52 Week Low
$4.25
Market cap
325.0M
Dividend yield
0.00%
Volume
384,241
Avg. volume
727,394
P/E ratio
-10.58